Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDPH.L Share News (DPH)

  • There is currently no data for DPH

DPH.L News

Dechra Pharmaceuticals hit by US supply issues, bad weather
10 Jul 2013

Dechra Pharmaceuticals hit by US supply issues, bad weather

Dechra Pharmaceuticals said adverse weather and supply issues in the US affected trading in the third quarter. In an update for the year to end of Ju...

Wednesday broker round-up UPDATE
10 Jul 2013

Wednesday broker round-up UPDATE

Anglo American: Goldman Sachs reduces target price from 1400p to 1100p and retains a sell recommendation. Antofagasta: Goldman Sachs takes target pri...

London open: Stocks edge higher ahead of FOMC minutes
10 Jul 2013

London open: Stocks edge higher ahead of FOMC minutes

The FTSE 100 opened higher on Wednesday morning, though gains were only slight as investors turned cautious ahead of a statement from the Federal Rese...

FTSE 250 movers: CSR leads the way after Q1 profits soar
8 May 2013

FTSE 250 movers: CSR leads the way after Q1 profits soar

Consumer electronics company CSR climbed into the top spot on Wednesday after it saw profits soar in the first quarter bolstered by strong sales of wi...

Dechra Pharmaceuticals posts rise in quarterly revenues
8 May 2013

Dechra Pharmaceuticals posts rise in quarterly revenues

Dechra Pharmaceuticals reported an increase in revenue in the first three months of the year as a rise in Europe sales offset a fall in the US. Group...

Friday broker round-up UPDATE
22 Mar 2013

Friday broker round-up UPDATE

Afren: Nomura shifts target price from 175p to 180p keeping a neutral rating. ASOS: Nomura increases target price from 2000p to 2630p, while reiterat...

Wednesday broker round-up UPDATE
27 Feb 2013

Wednesday broker round-up UPDATE

: Panmure Gordon reduces target price from 2159p to 1742p and reiterates its hold recommendation. Antofagasta: JP Morgan cuts target price from 1485p...

Dechra Pharmaceuticals records rise in revenues and profits
26 Feb 2013

Dechra Pharmaceuticals records rise in revenues and profits

Dechra Pharmaceuticals raised its dividend by 15.1 per cent as the company achieved higher revenues and profits during the second half of 2012. The v...